Literature DB >> 314938

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.

K Bosslet, V Schirrmacher, G Shantz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314938     DOI: 10.1002/ijc.2910240306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  18 in total

1.  In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity.

Authors:  V Schirrmacher; S Leidig; A Griesbach
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Authors:  H Schild; P von Hoegen; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.

Authors:  H D Haubeck; I Minkenberg; E Kölsch
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

4.  Syngeneic tumor cells can induce alloreactive T killer cells: a biological role for transplantation antigens.

Authors:  V Schirrmacher; D Hübsch; F Garrido
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity.

Authors:  V Schirrmacher; K Bosslet
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity.

Authors:  V Schirrmacher; R Heicappell
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

8.  Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.

Authors:  A Eisenthal; V Ramakrishna; Y Skornick; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

Review 9.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

10.  Assay for the determination of human carcinoma cells in circulating blood.

Authors:  R Schwartz; A Walk; H Toomes; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.